| Log in

Cipla New Ventures’ head Chandru Chawla on investment strategy, attractive segments & more

21 May, 2014

Cipla New Ventures (CNV) is a venture investment unit of one of country’s largest drugmakers Cipla Ltd. The company focuses on investments in innovation-led businesses like resea ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Exclusive: Cipla BioTec hires banker for biggest PE fundraise in biosimilar space

Exclusive: Cipla BioTec hires banker for biggest PE fundraise in biosimilar space

Ranjani R 1 year ago
Cipla BioTec Pvt Ltd, the bio-similar firm incubated by pharmaceuticals giant...
Cipla generates four-fold returns from Chase Pharma stake sale

Cipla generates four-fold returns from Chase Pharma stake sale

Joseph Rai 12 months ago
Drugmaker Cipla Ltd has sold its entire stake in the US-based Chase...
Drug maker Cipla floating venture fund to incubate startups

Drug maker Cipla floating venture fund to incubate startups

TEAM VCC 4 years ago
Indian pharma company Cipla Ltd is floating an in-house venture fund which will...
No Comments

Cipla New Ventures’ head Chandru Chawla on investment strategy, attractive segments & more

Powered by WordPress.com VIP